Investing.com - 在美国医疗保险和医疗补助服务中心(CMS)提出一项将大幅削减皮肤替代品Medicare支出的规则后,MiMedx Group (NASDAQ:MDXG)股价下跌19%,而Organogenesis Holdings (NASDAQ:ORGO)股价暴跌36%。 这项提案是2026财年Medicare医师费用表的一部分,旨在将皮肤替代品重新分类为"附带供应品"而非...
Source LinkInvesting.com - 在美国医疗保险和医疗补助服务中心(CMS)提出一项将大幅削减皮肤替代品Medicare支出的规则后,MiMedx Group (NASDAQ:MDXG)股价下跌19%,而Organogenesis Holdings (NASDAQ:ORGO)股价暴跌36%。 这项提案是2026财年Medicare医师费用表的一部分,旨在将皮肤替代品重新分类为"附带供应品"而非...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.